Song et al. [43] performed this method to identify two distinct molecular subtypes and develop a prognosis model in colorectal cancer, discovering the vital roles of PRGs in tumor immune microenvironment, clinicopathological features, and prognosis. The gene discussed is GART; the disease is colorectal cancer.